GMP manufacturing of biologics for Phase I/II clinical trials, reagents for diagnostics, or for research purposes is a logical extension of Paragon’s years of success with protein expression and purification projects. Under our business model, we are leveraging and transitioning many of our existing clients – from virtual companies to biotechnology and pharmaceutical companies – into our GMP suites and on to clinical trials.

Small batch, versatility, superior quality and ROI are the defining features of Paragon’s GMP manufacturing activities.